COURSE DESCRIPTION
This year marks the 20th anniversary of the New England Fertility Society. Our 2009 conference will use this occasion to take a critical look at the long-term outcomes of assisted reproductive technology as they have evolved since that first event. The program will feature a presentation on the under-discussed condition of male menopause; describe the emerging technologies used to interpret molecular signatures that may reflect implantation potential, as well as to potentially optimize implantation potential, of embryos, in vitro; address the significance of molecular species in our environment that may influence reproductive function; offer some insights into the condition of obesity at both a cellular level and a clinical level, and in particular as it affects female reproduction; and explore, through a debate, the application of assisted reproductive technology for unique circumstances. An array of roundtable luncheons will be offered at which these topics may be discussed in more depth, as well as provide opportunities for consideration of a variety of topics pertinent to the treatment of infertility. At the conclusion of the course, the registrants will have fresh perspectives on men, molecules and metabolism. The conference schedule has an informal interactive format allowing participants ample time to discuss the issues raised in lecture presentations. Several panel presentations will facilitate question and answer exchanges on topics of interest. A round table luncheon will provide opportunity for direct interaction and discussion with faculty. Regional research will also be showcased in poster presentations by registrants. TARGET AUDIENCE
This course addresses the needs of clinicians, nurses, embryologists, mental health professionals and other support staff. OBJECTIVES
At the conclusion of this program, the participant will be able to: 1. describe the condition of male menopause and its clinical correlates
2. describe the developing molecular techniques for evaluating human embryos and their implantation potential
3. describe the cellular and molecular events that underlie clinical obesity, their impact on female reproductive function, particularly as a symptom of polycystic ovarian syndrome
4. describe reproductive toxins that may be encountered in our environment
5. outline and discuss the various factors that may be considered when patients request treatment with the assisted reproductive technologies for non-clinical reasons | 
